Cargando…
Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations
Remimazolam is an ultra‐short acting benzodiazepine under development for procedural sedation and general anesthesia. Population pharmacokinetic analysis (PopPK) was conducted for remimazolam with arterial and venous samples previously, but results were limited by arterial‐venous concentration diffe...
Autores principales: | Zhou, Jie, Curd, Laura, Lohmer, Lauren L., Ossig, Joachim, Schippers, Frank, Stoehr, Thomas, Schmith, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877848/ https://www.ncbi.nlm.nih.gov/pubmed/33045130 http://dx.doi.org/10.1111/cts.12875 |
Ejemplares similares
-
A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation
por: Zhou, Jie, et al.
Publicado: (2021) -
Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia
por: Lohmer, Lauren L., et al.
Publicado: (2020) -
Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial
por: Pesic, Marija, et al.
Publicado: (2020) -
Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials
por: Dao, Van-Anh, et al.
Publicado: (2022) -
Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program
por: Hirano, Tatsuya, et al.
Publicado: (2023)